Gilead Sciences Inc (NASDAQ: GILD)
DRUGS - Biotechnology
Health Care
Stock price data as of
Closing price: $103.68
-
Support level$98.12
-
Resistance level$108.60
-
Beta0.3
-
RSI (14-day)50.1
- With a 59.0 percent return in the past year, this stock outperformed 90 percent of stocks in the S&P-100.
- GILD is one of this month's worst performers with a return of -7.7 percent, underperforming 90 percent of stocks in the S&P-100.
- Volatility is forecast to fall over the next month.
52-week low | 52-week high | Price as % of range |
---|---|---|
$63.15 | $117.41 | 79.9% |
200 day | 50 day | 20 day | 10 day |
---|---|---|---|
$92.57 | $109.08 | $104.87 | $104.96 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week7.7%
-
In the next month15.3%
-
In the next year47.8%
Period | Value |
---|---|
Historical (5 year) | 25.3% |
Last month | 23.5% |
Current estimate | 28.5% |
Next month forecast | 27.0% |